Experts in dermatology review the dosing and meal requirements need with isotretinoin administration, highlighting the impact and benefit of the novel lidose and micronized formulations.
Technology and care navigators are key to managing this growing population
Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.
Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
In this upcoming video series, James Q. Del Rosso, DO, will lead a conversation focusing on the practical considerations and clinical management of patients suffering from plaque psoriasis by reviewing the current treatment landscape and discussing individual patient cases.
For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Argyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Answers to some common questions about providing telehealth services in 2023.
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.
A key session at the annual meeting will share practical advice and tools to better support you and your patients.
Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.
In the final part of this Frontline Forum series, Joshua Zeichner, MD, FAAD; Hilary Baldwin, MD; Zoe Diana Draelos, MD; Aaron S. Farberg, MD, FAAD; and Leon H. Kircik, MD, discuss the main pillars of acne and topical treatments available for patients with acne.
The topical HDAC inhibitor remetinostat demonstrated favorable tolerability and clinically significant efficacy in reducing disease burden in patients with basal cell carcinoma, according to results from a phase 2 trial.
In this month's financial planning column, the OJM group talks about volatile markets and how to navigate investing in uncertain times.
Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.
The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.
The 2 votes came at the end of the second day of a joint meeting of the FDA's Drug Safety and Risk Management Advisory Committee and Dermatologic and Ophthalmic Drugs Advisory Committee.
Changes in the cutaneous microbiome triggered by warmer temperatures and increased UV radiation may stimulate C. acnes growth.